A Follow-up Study to Assess Safety and Tolerability of Galantamine Treatment in Individuals With Mild Cognitive Impairment

Clinical trial NCT00240695 · COMPLETED

Trial details

NCT number: NCT00240695
Sponsor: Johnson & Johnson Pharmaceutical Research & Development, L.L.C.
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Cognition Disorder Nervous System Diseases Mental Disorders Brain Diseases

Start date: 2003-05-01
Enrollment: 724

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.